Literature DB >> 22167504

Imaging features of primary and secondary malignant tumours of the sacrum.

E Thornton1, K M Krajewski, K N O'Regan, A A Giardino, J P Jagannathan, N Ramaiya.   

Abstract

Malignant tumours of the sacrum may be primary or secondary. While sacral metastases are frequently encountered, a diagnostic dilemma can present when there is a single sacral bone tumour with no history or evidence of malignancy elsewhere in the body. Familiarity with the imaging features and clinical presentations of primary malignant bone tumours is helpful in narrowing the differential. This pictorial review will illustrate with both common and uncommon malignant sacral tumours CT, MRI and positron emission tomography/CT, highlighting the specific features of each.

Entities:  

Mesh:

Year:  2011        PMID: 22167504      PMCID: PMC3473982          DOI: 10.1259/bjr/25247602

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


  25 in total

1.  Imaging of sacral masses: self-assessment module.

Authors:  Alice S Ha; Felix S Chew
Journal:  AJR Am J Roentgenol       Date:  2010-09       Impact factor: 3.959

2.  Primary non-Hodgkin lymphoma of the spine.

Authors:  S Becker; J Babisch; R Venbrocks; D Katenkamp; S Wurdinger
Journal:  Arch Orthop Trauma Surg       Date:  1998       Impact factor: 3.067

Review 3.  The sacrum: pathologic spectrum, multimodality imaging, and subspecialty approach.

Authors:  J Diel; O Ortiz; R A Losada; D B Price; M W Hayt; D S Katz
Journal:  Radiographics       Date:  2001 Jan-Feb       Impact factor: 5.333

Review 4.  From the archives of the AFIP. Primary tumors of the spine: radiologic pathologic correlation.

Authors:  M D Murphey; C L Andrews; D J Flemming; H T Temple; W S Smith; J G Smirniotopoulos
Journal:  Radiographics       Date:  1996-09       Impact factor: 5.333

Review 5.  Positron emission tomography and bone metastases.

Authors:  Ignac Fogelman; Gary Cook; Ora Israel; Hans Van der Wall
Journal:  Semin Nucl Med       Date:  2005-04       Impact factor: 4.446

6.  Evaluation of neoadjuvant therapy response of osteogenic sarcoma using FDG PET.

Authors:  M Schulte; D Brecht-Krauss; M Werner; E Hartwig; M R Sarkar; P Keppler; J Kotzerke; A Guhlmann; G Delling; S N Reske
Journal:  J Nucl Med       Date:  1999-10       Impact factor: 10.057

7.  Sacrococcygeal chordoma: MR imaging in 30 patients.

Authors:  Mi Sook Sung; Gyung Kyu Lee; Heung Sik Kang; Soon Tae Kwon; Jin Gyoon Park; Jin Suk Suh; Gil Ho Cho; Sung Moon Lee; Myung Hee Chung; Donald Resnick
Journal:  Skeletal Radiol       Date:  2004-10-08       Impact factor: 2.199

Review 8.  From the archives of the AFIP: imaging of primary chondrosarcoma: radiologic-pathologic correlation.

Authors:  Mark D Murphey; Eric A Walker; Anthony J Wilson; Mark J Kransdorf; H Thomas Temple; Francis H Gannon
Journal:  Radiographics       Date:  2003 Sep-Oct       Impact factor: 5.333

Review 9.  Imaging of sacral tumors.

Authors:  Betty Jean Manaster; Travis Graham
Journal:  Neurosurg Focus       Date:  2003-08-15       Impact factor: 4.047

10.  Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose.

Authors:  P D Shreve; H B Grossman; M D Gross; R L Wahl
Journal:  Radiology       Date:  1996-06       Impact factor: 11.105

View more
  12 in total

1.  Lumbopelvic shortening and local host bone-to-host bone reconstruction: a surgical method for lumbopelvic fusion following total sacrectomy.

Authors:  Ahmed Cherry; Colby Oitment; Jay Wunder; Peter Ferguson; Raja Rampersaud
Journal:  Eur Spine J       Date:  2022-09-03       Impact factor: 2.721

2.  Comparison of radiomics machine-learning classifiers and feature selection for differentiation of sacral chordoma and sacral giant cell tumour based on 3D computed tomography features.

Authors:  Ping Yin; Ning Mao; Chao Zhao; Jiangfen Wu; Chao Sun; Lei Chen; Nan Hong
Journal:  Eur Radiol       Date:  2018-10-02       Impact factor: 5.315

3.  Difficulty distinguishing benign notochordal cell tumor from chordoma further suggests a link between them.

Authors:  Jennifer Kreshak; Frédérique Larousserie; Piero Picci; Stefano Boriani; Joseph Mirra; Biagio Merlino; Eugenio Brunocilla; Daniel Vanel
Journal:  Cancer Imaging       Date:  2014-04-22       Impact factor: 3.909

4.  Primary neuroendocrine tumor in the presacral region: A case report.

Authors:  Rui Zhang; Yong Zhu; Xiao-Bo Huang; Chris Deng; Min Li; Guang-Shu Shen; Shu-Liang Huang; Shao-Hua Huangfu; Yan-Ni Liu; Chun-Gen Zhou; Ling Wang; Qi Zhang; Youping Deng; Bin Jiang
Journal:  World J Clin Cases       Date:  2019-07-26       Impact factor: 1.337

5.  Angioleiomyoma of the sacrum: a case report and literature review of similar sacral lesions.

Authors:  Xianchen Zhang; Luping Liu
Journal:  Radiol Case Rep       Date:  2021-04-10

6.  High fluorodeoxyglucose ((18)F)PET-uptake lymph nodes in a patient with chordoma: Tumor metastasis or sarcoidosis?

Authors:  Mohamad Hossain Gharavi; Hope Hueizhi Wu; Steven A Toms
Journal:  Am J Case Rep       Date:  2013-09-17

7.  Humeral metastasis of sacrococcygeal chordoma detected by fluorine-18 fluorodeoxyglucose positron emission tomography-computed tomography: A case report.

Authors:  Futao Cui; Minggang Su; Han Zhang; Rong Tian
Journal:  Radiol Case Rep       Date:  2018-03-07

8.  Sacral Tumours on MRI: A Pictorial Essay.

Authors:  Eva Vanheule; Wouter Huysse; Nele Herregods; Koenraad Verstraete; Lennart Jans
Journal:  J Belg Soc Radiol       Date:  2019-11-08       Impact factor: 1.894

9.  Machine and Deep Learning Based Radiomics Models for Preoperative Prediction of Benign and Malignant Sacral Tumors.

Authors:  Ping Yin; Ning Mao; Hao Chen; Chao Sun; Sicong Wang; Xia Liu; Nan Hong
Journal:  Front Oncol       Date:  2020-10-16       Impact factor: 6.244

10.  Primary sacral non-Hodgkin's lymphoma: report of a case and systematic review of literature.

Authors:  Satya Vijay Chigurupati; Mridula Shukla; Manoj Pandey
Journal:  World J Surg Oncol       Date:  2021-02-24       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.